Clinical evaluation of the Carisolv chemomechanical caries removal technique according to the site/stage concept, a revised caries classification system.
The objective of the present study was to assess the efficiency and benefit of a chemomechanical system for carious dentin removal, Carisolv, in general practice. A revised caries classification, the site/stage concept, was used to describe the clinical situations of all carious lesions treated. The study was performed by 12 investigators, and 120 carious lesions were treated with Carisolv. Sixty percent of the cases were treated without anaesthesia, and we found a significant correlation between chemomechanical treatment without anaesthesia and absence of pain ( P=0.01). In 78.3% of the cases, carious dentin was totally removed with Carisolv, and in 21.7%, the dentin treatment was completed by drilling. In cases performed with Carisolv alone, the time required to remove carious dentin was 11.1+/-9.51 min (mean+/-SD). Treatment time was equivalent for all sites and increased significantly with each successive stage of lesion progression ( P<0.001). In 82.5% of cases, the clinicians were satisfied with Carisolv, and in 99.2%, so were the patients. We conclude that, using clinical examination methods, Carisolv seems to remove carious dentin at all sites and stages of carious lesions but must be made more efficient for use in general practice.
Chaussain-Miller
C
C
Department of Conservative Dentistry and Endodontics, Faculty of Dental Surgery, University Paris 5, Montrouge, France.
Decup
F
F
Domejean-Orliaguet
S
S
Gillet
D
D
Guigand
M
M
Kaleka
R
R
Laboux
O
O
Lafont
J
J
Medioni
E
E
Serfaty
R
R
Toumelin-Chemla
F
F
Tubiana
J
J
Lasfargues
J J
JJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000766:Anesthesia, Dental; D002648:Child; D003731:Dental Caries / Q000145:classification* / Q000628:therapy*; D003737:Dental Cavity Preparation / Q000379:methods*; D003804:Dentin; D005260:Female; D018698:Glutamic Acid / Q000627:therapeutic use*; D006801:Humans; D007930:Leucine / Q000627:therapeutic use*; D008239:Lysine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D011795:Surveys and Questionnaires; D013997:Time Factors
C119934:Carisolv; D018698:Glutamic Acid; D007930:Leucine; D008239:Lysine